Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Fulgent Genetics, |
RCV005017938 | SCV005644434 | likely pathogenic | Chédiak-Higashi syndrome | 2024-04-03 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV005017938 | SCV005717698 | pathogenic | Chédiak-Higashi syndrome | 2024-03-18 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Ser2719*) in the LYST gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in LYST are known to be pathogenic (PMID: 9215679, 11857544). This variant is present in population databases (no rsID available, gnomAD 0.01%). This variant has not been reported in the literature in individuals affected with LYST-related conditions. For these reasons, this variant has been classified as Pathogenic. |